Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years)

South African Medical Journal

Volumn 103, Issue 10, 2013, Pages 714-715

  Schaaf, H S ^a   Cotton, M F ^a   Boon, G P G ^b   Jeena, P M ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b WALTER SISULU UNIVERSITY   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; RIFAMPICIN;

ARTICLE; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; PRACTICE GUIDELINE; PROPHYLAXIS; SINGLE DRUG DOSE; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; TUBERCULOSIS;

EID: 84885051775     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7189     Document Type: Article

References (16)

1. World Health Organization. WHO policy on collaborative TB/HIV activities. Guidelines for national programmes and other stakeholders. WHO/HTM/TB/2012.1 and WHO/HIV/2012.1. WHO: Geneva, Switzerland, 2012.
2. Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011;365:21-31. [http://dx.doi.org/10.1056/NEJMoa1011214]
3. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence oftuberculosis in children with HIV: Randomised controlled trial. BMJ 2007;334(7585):136.
4. Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011;66(6):496-501. [http://dx.doi.org/10.1136/thx.2010.156752]
5. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8(4):392-402.
6. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infectedinfants: Evidence from a South African population-based study highlights the need for improvedtuberculosis control strategies. Clin Infect Dis 2009;48(1):108-114. [http://dx.doi.org/10.1086/595012]
7. Schaaf HS, Michaelis IA, Richardson M, et al. Adult to child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis 2003;7(5):426-431.
8. Walters LE, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatrics 2008;8(1):1. [http://dx.doi.org/10.1186/1471-2431-8-1]
9. Edmonds A, Lusiama J, Napravnik S, Kitetele F, van Rie A, Behets F. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol 2009;38(6):1612-1621. [http://dx.doi.org/10.1093/ije/dyp208]
10. Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: A prospective cohort. AIDS 2009;23(5):631-636. [http://dx.doi.org/10.1097/QAD.0b013e328327964f]
11. Le Roux SM, Cotton MF, Myer L, et al. Safety of long-term isoniazid preventive therapy in children with HIV: A comparison of two dosing schedules. Int J Tuberc Lung Dis 2013;17(1):26-31. [http://dx.doi.org/10.5588/ijtld.11.0820]
12. Cotton MF. INH preventive therapy (IPT) in HIV-infected South African children. S Afr J HIV Med 2011;12(2):27-30. http://www.sahivsoc.org/upload/documents/guidelines_june_2011b.pdf (accessed22 June 2013).
13. Department of Health. National Tuberculosis Management Guidelines: 2009. Pretoria: Department of Health, 2009. http://familymedicine.ukzn.ac.za/Libraries/Guidelines_Protocols/TB_Guidelines_2009.sflb.ashx (accessed 22 June 2013).
14. Department of Health. Guidelines for Tuberculosis Preventive Therapy among HIV infectedIndividuals in South Africa: 2010. Pretoria: Department of Health, 2010. http://hivfshealth.org/document/2010/08/17/guidelines-for-tubercolosis-preventative-therapy-among-hiv-individuals-of-south-africa (accessed 31 May 2013).
15. Seddon JA, Godfrey-Faussett P, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Management of children exposed to multidrug-resistant Mycobacterium tuberculosis. Lancet Infect Dis 2012;12(6):469-479.[http://dx.doi.org/10.1016/S1473-3099(11)70366-8]
16. European Center for Disease Prevention and Control. Management of Contacts of MDR TB andXDR TB Patients. http://ecdc.europa.eu/en/publications/Publications/201203-Guidance-MDR-TB-contacts.pdf (accessed 20 May 2013.)